1. Helicobacter pylori Infection in Pediatric Patients Living in Europe: Results of the EuroPedHP Registry 2013 to 2016
- Author
-
Kori, Michal, Le Thi, Thu Giang, Werkstetter, Katharina, Sustmann, Andrea, Bontems, Patrick, Lopes, Ana Isabel, Oleastro, Monica, Iwanczak, Barbara, Kalach, Nicolas, Misak, Zrinjka, Cabral, José, Homan, Matjaž, Cilleruelo Pascual, Maria Luz, Pehlivanoglu, Ender, Casswall, Thomas, Urruzuno, Pedro, Martinez Gomez, Maria José, Papadopoulou, Alexandra, Roma, Eleftheria, Dolinsek, Jernej, Rogalidou, Maria, Urbonas, Vaidotas, Chong, Sonny, Kindermann, Angelika, Miele, Erasmo, Rea, Francesca, Cseh, Áron, Koletzko, Sibylle, Helicobacter pylori Working Group of ESPGHAN, İstanbul Kent Üniversitesi, Fakülteler, Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Pehlivanoğlu, Ender, Kori, M., Le Thi, T. G., Werkstetter, K., Sustmann, A., Bontems, P., Lopes, A. I., Oleastro, M., Iwanczak, B., Kalach, N., Misak, Z., Cabral, J., Homan, M., Cilleruelo Pascual, M. L., Pehlivanoglu, E., Casswall, T., Urruzuno, P., Martinez Gomez, M. J., Papadopoulou, A., Roma, E., Dolinsek, J., Rogalidou, M., Urbonas, V., Chong, S., Kindermann, A., Miele, E., Rea, F., Cseh, A., Koletzko, S., Paediatric Gastroenterology, Amsterdam Gastroenterology Endocrinology Metabolism, and Amsterdam Reproduction & Development (AR&D)
- Subjects
Male ,HDE GAS PED ,medicine.medical_specialty ,Turkey ,Pédiatrie ,Peptic ,Group B ,Helicobacter Infections ,03 medical and health sciences ,0302 clinical medicine ,Clarithromycin ,Metronidazole ,030225 pediatrics ,Internal medicine ,Gastro-entérologie ,Humans ,Medicine ,Registries ,Israel ,Child ,Pediatric gastroenterology ,Helicobacter pylori ,biology ,business.industry ,Gastroenterology ,Amoxicillin ,Endoscopy ,Odds ratio ,biology.organism_classification ,Helicobacter Pylori ,Abdominal Pain ,Anti-Bacterial Agents ,Europe ,Infecções Gastrointestinais ,Pediatrics, Perinatology and Child Health ,Pediatric Gastroenterology ,Drug Therapy, Combination ,Female ,030211 gastroenterology & hepatology ,business ,Peptic Ulcer Disease ,medicine.drug - Abstract
OBJECTIVES: The aim of the study was to assess clinical presentation, endoscopic findings, antibiotic susceptibility and treatment success of Helicobacter pylori (H. pylori) infected pediatric patients. METHODS: Between 2013 and 2016, 23 pediatric hospitals from 17 countries prospectively submitted data on consecutive H. pylori-infected (culture positive) patients to the EuroPedHP-Registry. RESULTS: Of 1333 patients recruited (55.1% girls, median age 12.6 years), 1168 (87.6%) were therapy naïve (group A) and 165 (12.4%) had failed treatment (group B). Patients resided in North/Western (29.6%), Southern (34.1%) and Eastern Europe (23.0%), or Israel/Turkey (13.4%). Main indications for endoscopy were abdominal pain or dyspepsia (81.2%, 1078/1328). Antral nodularity was reported in 77.8% (1031/1326) of patients, gastric or duodenal ulcers and erosions in 5.1% and 12.8%, respectively. Primary resistance to clarithromycin (CLA) and metronidazole (MET) occurred in 25% and 21%, respectively, and increased after failed therapy. Bacterial strains were fully susceptible in 60.5% of group A, but in only 27.4% of group B. Primary CLA resistance was higher in Southern and Eastern Europe (adjusted odds ratio [ORadj] = 3.44, 95% confidence interval [CI] 2.22-5.32, P, SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2020